ICU Medical (NASDAQ:ICUI) Stock Rating Upgraded by Wall Street Zen

ICU Medical (NASDAQ:ICUI) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Sunday.

ICUI has been the subject of several other research reports. KeyCorp upped their target price on shares of ICU Medical from $173.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Piper Sandler upped their price objective on shares of ICU Medical from $153.00 to $172.00 and gave the company an “overweight” rating in a report on Friday, November 7th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of ICU Medical in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $175.67.

ICU Medical Trading Up 2.0%

ICU Medical stock opened at $144.90 on Friday. The stock has a market capitalization of $3.58 billion, a P/E ratio of -467.40 and a beta of 0.79. ICU Medical has a 52 week low of $107.00 and a 52 week high of $165.17. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.19 and a current ratio of 2.45. The stock has a 50-day simple moving average of $148.95 and a 200 day simple moving average of $135.14.

Institutional Trading of ICU Medical

Hedge funds have recently modified their holdings of the business. Hilton Head Capital Partners LLC bought a new stake in ICU Medical in the fourth quarter worth $32,000. Cullen Frost Bankers Inc. purchased a new position in shares of ICU Medical during the 2nd quarter worth $38,000. SJS Investment Consulting Inc. lifted its position in ICU Medical by 41,000.0% during the third quarter. SJS Investment Consulting Inc. now owns 411 shares of the medical instruments supplier’s stock valued at $49,000 after purchasing an additional 410 shares in the last quarter. Covestor Ltd increased its position in ICU Medical by 70.7% in the third quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier’s stock worth $68,000 after buying an additional 236 shares in the last quarter. Finally, Strs Ohio raised its stake in ICU Medical by 60.0% during the 4th quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock worth $114,000 after acquiring an additional 300 shares during the period. Institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.